lOMoAR cPSD| 13728229
lOMoAR cPSD| 13728229
Complete Test Bank Lilleys Pharmacology for Can
V V V V V V
h Care Practice 4th Edition Sealock Questions &
V V V V V V V V
wers with rationales (Chapter 1-58) Updated2
V V V V V V
Lilleys Pharmacology for Canadian Health Care Practic
V V V V V V
Sealock Test Bank V V
Professionhood and the Knowledge of Nursing I
V V V V V V
, lOMoAR cPSD| 13728229
Chapter 01: Nursing Practice in Canada and Drug Therapy
V V V V V V V V
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
V V V V V V V V V
MULTIPLEVCHOICE
1. WhichVisVaVjudgementVaboutVaVparticularVpatient’sVpotentialVneedVorVproblem?
a. AVgoal
b. AnVassessment
c. SubjectiveVdata
d. AVnursingVdiagnosis
ANS:V D
NursingVdiagnosisVisVtheVphaseVofVtheVnursingVprocessVduringVwhichVaVclinicalVjudgementVisVmadeVabou
VtoV
heathVconditionsVandVlifeVprocessesVorVvulnerabilityVforVthatVresponse.
DIF: CognitiveVLevel:VKnowledge
2. TheVpatientVisVtoVreceiveVoralVfurosemideV(Lasix)VeveryVday;Vhowever,VbecauseVtheVpatientVisVunableVto
akeVmedicationVorally,VasVordered.VTheVnurseVneedsVtoVcontactVtheVphysician.VWhatVtypeVofVproblemVisV
a. AV“rightVtime”Vproblem
b. AV“rightVdose”Vproblem
c. AV“rightVroute”Vproblem
d. AV“rightVmedication”Vproblem
ANS:V C
ThisVisVaV“rightVroute”Vproblem:VtheVnurseVcannotVassumeVtheVrouteVandVmustVclarifyVtheVrouteVwithVthe
ghtVtime”VproblemVbecauseVtheVorderedVfrequencyVhasVnotVchanged.VThisVisVnotVaV“rightVdose”Vproblem
tedVtoVanVinabilityVtoVswallow.VThisVisVnotVaV“rightVmedication”VproblemVbecauseVtheVmedicationVorder
route.
DIF: CognitiveVLevel:VApplication
3. TheVnurseVhasVbeenVmonitoringVtheVpatient’sVprogressVonVhisVnewVdrugVregimenVsinceVtheVfirstVdoseVan
gnsVofVpossibleVadverseVeffects.VWhatVnursingVprocessVphaseVisVtheVnurseVpractising?
a. Planning
b. Evaluation
c. Implementation
d. NursingVdiagnosis
ANS:V B
MonitoringVtheVpatient’sVprogressVisVpartVofVtheVevaluationVphase.VPlanning,Vimplementation,VandVnursi
otVillustratedVbyVthisVexample.
DIF: CognitiveVLevel:VApplication
4. TheVnurseVisVcaringVforVaVpatientVwhoVhasVbeenVnewlyVdiagnosedVwithVtypeV1VdiabetesVmellitus.VWhich
anVoutcomeVcriterionVforVthisVpatient?
a. TheVpatientVwillVfollowVinstructions.
b. TheVpatientVwillVnotVexperienceVcomplications.
c. TheVpatientVadheresVtoVtheVnewVinsulinVtreatmentVregimen.
d. TheVpatientVdemonstratesVsafeVinsulinVself-administrationVtechnique.
ANS:V D
HavingVtheVpatientVdemonstrateVsafeVinsulinVself-
administrationVtechniqueVisVaVspecificVandVmeasurableVoutcomeVcriterion.VFollowingVinstructionsVandVa
tVspecificVcriteria.VAdherenceVtoVtheVnewVinsulinVtreatmentVregimenVisVnotVobjectiveVandVwouldVbeVdiff
DIF: CognitiveVLevel:VApplication
, lOMoAR cPSD| 13728229
6. TheVnurseVisVworkingVduringVaVveryVbusyVnightVshift,VandVtheVhealthVcareVproviderVhasVjustVgivenVtheVn
verVtheVtelephone,VbutVtheVnurseVdoesVnotVrecallVtheVroute.VWhatVisVtheVbestVwayVforVtheVnurseVtoVavoidV
a. RecopyVtheVorderVneatlyVonVtheVorderVsheet,VwithVtheVmostVcommonVrouteVindicated
b. ConsultVwithVtheVpharmacistVforVclarificationVaboutVtheVmostVcommonVroute
c. CallVtheVhealthVcareVproviderVtoVclarifyVtheVrouteVofVadministration
d. WithholdVtheVdrugVuntilVtheVhealthVcareVproviderVvisitsVtheVpatient
ANS:V C
IfVaVmedicationVorderVdoesVnotVincludeVtheVroute,VtheVnurseVmustVaskVtheVhealthVcareVproviderVtoVclarify
eVofVadministration.
DIF: CognitiveVLevel:VApplicationV|VCognitiveVLevel:VAnalysis
7. WhichVconstitutesVtheVtraditionalVFiveVRightsVofVmedicationVadministration?
a. RightVdrug,VrightVroute,VrightVdose,VrightVtime,VandVrightVpatient
b. RightVdrug,VtheVrightVeffect,VtheVrightVroute,VtheVrightVtime,VandVtheVrightVpatient
c. RightVpatient,VrightVstrength,VrightVdiagnosis,VrightVdrug,VandVrightVroute
d. RightVpatient,VrightVdiagnosis,VrightVdrug,VrightVroute,VandVrightVtime
ANS:V A
TheVtraditionalVFiveVRightsVofVmedicationVadministrationVwereVconsideredVtoVbeVRightVdrug,VRightVrou
RightVpatient.VRightVeffect,VrightVstrength,VandVrightVdiagnosisVareVnotVpartVofVtheVtraditionalVFiveVRigh
DIF: CognitiveVLevel:VComprehension
8. WhatVcorrectlyVdescribesVtheVnursingVprocess?
a. Diagnosing,Vplanning,Vassessing,Vimplementing,VandVfinallyVevaluating
b. Assessing,VthenVdiagnosing,Vimplementing,VandVendingVwithVevaluating
c. AVlinearVdirectionVthatVbeginsVwithVassessingVandVcontinuesVthroughVdiagnosin
g,Vplanning,VandVfinallyVimplementing
d. AnVongoingVprocessVthatVbeginsVwithVassessingVandVcontinuesVwithVdiagnosin
g,Vplanning,Vimplementing,VandVevaluating
ANS:V D
TheVnursingVprocessVisVanVongoing,Vflexible,Vadaptable,VandVadjustableVfive-
stepVprocessVthatVbeginsVwithVassessingVandVcontinuesVthroughVdiagnosing,Vplanning,Vimplementing,Van
chVmayVthenVleadVbackVtoVanyVofVtheVotherVphases.
DIF: CognitiveVLevel:VApplication
9. WhenVtheVnurseVisVconsideringVtheVtimingVofVaVdrugVdose,VwhichVisVmostVimportantVtoVassess?
a. TheVpatient’sVidentification
b. TheVpatient’sVweight
c. TheVpatient’sVlastVmeal
d. AnyVdrugVorVfoodVallergies
ANS:V C
TheVpharmacokineticVandVpharmacodynamicVpropertiesVofVtheVdrugVneedVtoVbeVassessedVwithVregardVto
foodVinteractionsVorVcompatibilityVissues.VTheVpatient’sVidentification,Vweight,VandVdrugVorVfoodVallergie
ug’sVtiming.
DIF: CognitiveVLevel:VApplication
10. TheVnurseVisVwritingVnursingVdiagnosesVforVaVplanVofVcare.VWhichVreflectsVtheVcorrectVformatVforVherVnu
a. Anxiety
b. AnxietyVrelatedVtoVnewVdrugVtherapy
c. AnxietyVrelatedVtoVanxiousVfeelingsVaboutVdrugVtherapy,VasVevidencedVb
yVstatementsVsuchVasV“I’mVupsetVaboutVhavingVtoVgiveVmyselfVshots”
d. AnxietyVrelatedVtoVnewVdrugVtherapy,VasVevidencedVbyVstatementsVsuchVasV“I’
mVupsetVaboutVhavingVtoVgiveVmyselfVshots”
, lOMoAR cPSD| 13728229
Chapter 02: Pharmacological Principles
V V V
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
V V V V V V V V V
MULTIPLEVCHOICE
1. AVpatientVisVreceivingVtwoVdifferentVdrugs,Vwhich,VatVtheirVcurrentVdoseVformsVandVdosages,VareVbothVab
VinVidenticalVamounts.VWhichVtermVbestVdenotesVthatVtheVdrugsVhaveVtheVsameVabsorptionVrates?
a. Equivalent
b. Synergistic
c. Compatible
d. Bioequivalent
ANS:V D
TwoVdrugsVabsorbedVintoVtheVcirculationVatVtheVsameVamountV(inVspecificVdosageVforms)VhaveVtheVsame
areVbioequivalent.V“Equivalent”VisVincorrectVbecauseVtheVtermV“bioavailability”VisVusedVtoVexpressVtheVe
ynergistic”VisVincorrectVbecauseVthisVtermVrefersVtoVtwoVdrugsVgivenVtogetherVwhoseVresultingVeffectVisV
effectsVofVeachVdrugVgivenValone.V“Compatible”VisVincorrectVbecauseVthisVtermVisVaVgeneralVtermVusedVt
esVdoVnotVhaveVaVchemicalVreactionVwhenVmixedV(orVgiven,VinVtheVcaseVofVdrugs)Vtogether.
DIF: CognitiveVLevel:VComprehension
2. AVpatientVisVreceivingVmedicationVviaVintravenousVinjection.VWhichVinformationVshouldVtheVnurseVprov
a. TheVmedicationVwillVcauseVfewerVadverseVeffectsVwhenVgivenVintravenously.
b. TheVmedicationVwillVbeVabsorbedVslowlyVintoVtheVtissuesVoverVtime.
c. TheVmedication’sVactionVwillVbeginVfasterVwhenVgivenVintravenously.
d. MostVofVtheVdrugVisVinactivatedVbyVtheVliverVbeforeVitVreachesVtheVtargetVarea.
ANS:V C
IntravenousVinjectionsVareVtheVfastestVrouteVofVabsorption.VTheVintravenousVrouteVdoesVnotVaffectVtheVnu
heVintravenousVrouteVisVnotVaVslowVrouteVofVabsorption,VandVtheVintravenousVrouteVdoesVnotVcauseVinacti
liverVbeforeVitVreachesVtheVtargetVarea.
DIF: CognitiveVLevel:VComprehension
3. WhichVisVtrueVregardingVparenteralVdrugs?
a. TheyVbypassVtheVfirst-passVeffect.
b. TheyVdecreaseVbloodVflowVtoVtheVstomach.
c. TheyVareValteredVbyVtheVpresenceVofVfoodVinVtheVstomach.
d. TheyVexertVtheirVeffectsVwhileVcirculatingVinVtheVbloodstream.
ANS:V A
DrugsVgivenVbyVtheVparenteralVrouteVbypassVtheVfirst-
passVeffect,VbutVtheyVstillVmustVbeVabsorbedVintoVcellsVandVtissuesV beforeVtheyVcanVexertVtheirVeffects.VEn
lly),VnotVparenteralVdrugs,VdecreaseVbloodVflowVtoVtheVstomachVandVareValteredVbyVtheVpresenceVofVfood
drugsVmustVbeVabsorbedVintoVcellsVandVtissuesVfromVtheVcirculationVbeforeVtheyVcanVexertVtheirVeffects;V
tsVwhileVcirculatingVinVtheVbloodstream.
DIF: CognitiveVLevel:VAnalysis
4. AVdrug’sVhalf-lifeVisVbestVdefinedVas
a. TheVtimeVitVtakesVforVtheVdrugVtoVelicitVhalfVitsVtherapeuticVresponse.
b. TheVtimeVitVtakesVone-
halfVofVtheVoriginalVamountVofVaVdrugVtoVreachVtheVtargetVcells.
c. TheVtimeVitVtakesVone-
halfVofVtheVoriginalVamountVofVaVdrugVtoVbeVremovedVfromVtheVbody.
d. TheVtimeVitVtakesVone-
halfVofVtheVoriginalVamountVofVaVdrugVtoVbeVabsorbedVintoVtheVcirculation.
ANS:V C
lOMoAR cPSD| 13728229
Complete Test Bank Lilleys Pharmacology for Can
V V V V V V
h Care Practice 4th Edition Sealock Questions &
V V V V V V V V
wers with rationales (Chapter 1-58) Updated2
V V V V V V
Lilleys Pharmacology for Canadian Health Care Practic
V V V V V V
Sealock Test Bank V V
Professionhood and the Knowledge of Nursing I
V V V V V V
, lOMoAR cPSD| 13728229
Chapter 01: Nursing Practice in Canada and Drug Therapy
V V V V V V V V
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
V V V V V V V V V
MULTIPLEVCHOICE
1. WhichVisVaVjudgementVaboutVaVparticularVpatient’sVpotentialVneedVorVproblem?
a. AVgoal
b. AnVassessment
c. SubjectiveVdata
d. AVnursingVdiagnosis
ANS:V D
NursingVdiagnosisVisVtheVphaseVofVtheVnursingVprocessVduringVwhichVaVclinicalVjudgementVisVmadeVabou
VtoV
heathVconditionsVandVlifeVprocessesVorVvulnerabilityVforVthatVresponse.
DIF: CognitiveVLevel:VKnowledge
2. TheVpatientVisVtoVreceiveVoralVfurosemideV(Lasix)VeveryVday;Vhowever,VbecauseVtheVpatientVisVunableVto
akeVmedicationVorally,VasVordered.VTheVnurseVneedsVtoVcontactVtheVphysician.VWhatVtypeVofVproblemVisV
a. AV“rightVtime”Vproblem
b. AV“rightVdose”Vproblem
c. AV“rightVroute”Vproblem
d. AV“rightVmedication”Vproblem
ANS:V C
ThisVisVaV“rightVroute”Vproblem:VtheVnurseVcannotVassumeVtheVrouteVandVmustVclarifyVtheVrouteVwithVthe
ghtVtime”VproblemVbecauseVtheVorderedVfrequencyVhasVnotVchanged.VThisVisVnotVaV“rightVdose”Vproblem
tedVtoVanVinabilityVtoVswallow.VThisVisVnotVaV“rightVmedication”VproblemVbecauseVtheVmedicationVorder
route.
DIF: CognitiveVLevel:VApplication
3. TheVnurseVhasVbeenVmonitoringVtheVpatient’sVprogressVonVhisVnewVdrugVregimenVsinceVtheVfirstVdoseVan
gnsVofVpossibleVadverseVeffects.VWhatVnursingVprocessVphaseVisVtheVnurseVpractising?
a. Planning
b. Evaluation
c. Implementation
d. NursingVdiagnosis
ANS:V B
MonitoringVtheVpatient’sVprogressVisVpartVofVtheVevaluationVphase.VPlanning,Vimplementation,VandVnursi
otVillustratedVbyVthisVexample.
DIF: CognitiveVLevel:VApplication
4. TheVnurseVisVcaringVforVaVpatientVwhoVhasVbeenVnewlyVdiagnosedVwithVtypeV1VdiabetesVmellitus.VWhich
anVoutcomeVcriterionVforVthisVpatient?
a. TheVpatientVwillVfollowVinstructions.
b. TheVpatientVwillVnotVexperienceVcomplications.
c. TheVpatientVadheresVtoVtheVnewVinsulinVtreatmentVregimen.
d. TheVpatientVdemonstratesVsafeVinsulinVself-administrationVtechnique.
ANS:V D
HavingVtheVpatientVdemonstrateVsafeVinsulinVself-
administrationVtechniqueVisVaVspecificVandVmeasurableVoutcomeVcriterion.VFollowingVinstructionsVandVa
tVspecificVcriteria.VAdherenceVtoVtheVnewVinsulinVtreatmentVregimenVisVnotVobjectiveVandVwouldVbeVdiff
DIF: CognitiveVLevel:VApplication
, lOMoAR cPSD| 13728229
6. TheVnurseVisVworkingVduringVaVveryVbusyVnightVshift,VandVtheVhealthVcareVproviderVhasVjustVgivenVtheVn
verVtheVtelephone,VbutVtheVnurseVdoesVnotVrecallVtheVroute.VWhatVisVtheVbestVwayVforVtheVnurseVtoVavoidV
a. RecopyVtheVorderVneatlyVonVtheVorderVsheet,VwithVtheVmostVcommonVrouteVindicated
b. ConsultVwithVtheVpharmacistVforVclarificationVaboutVtheVmostVcommonVroute
c. CallVtheVhealthVcareVproviderVtoVclarifyVtheVrouteVofVadministration
d. WithholdVtheVdrugVuntilVtheVhealthVcareVproviderVvisitsVtheVpatient
ANS:V C
IfVaVmedicationVorderVdoesVnotVincludeVtheVroute,VtheVnurseVmustVaskVtheVhealthVcareVproviderVtoVclarify
eVofVadministration.
DIF: CognitiveVLevel:VApplicationV|VCognitiveVLevel:VAnalysis
7. WhichVconstitutesVtheVtraditionalVFiveVRightsVofVmedicationVadministration?
a. RightVdrug,VrightVroute,VrightVdose,VrightVtime,VandVrightVpatient
b. RightVdrug,VtheVrightVeffect,VtheVrightVroute,VtheVrightVtime,VandVtheVrightVpatient
c. RightVpatient,VrightVstrength,VrightVdiagnosis,VrightVdrug,VandVrightVroute
d. RightVpatient,VrightVdiagnosis,VrightVdrug,VrightVroute,VandVrightVtime
ANS:V A
TheVtraditionalVFiveVRightsVofVmedicationVadministrationVwereVconsideredVtoVbeVRightVdrug,VRightVrou
RightVpatient.VRightVeffect,VrightVstrength,VandVrightVdiagnosisVareVnotVpartVofVtheVtraditionalVFiveVRigh
DIF: CognitiveVLevel:VComprehension
8. WhatVcorrectlyVdescribesVtheVnursingVprocess?
a. Diagnosing,Vplanning,Vassessing,Vimplementing,VandVfinallyVevaluating
b. Assessing,VthenVdiagnosing,Vimplementing,VandVendingVwithVevaluating
c. AVlinearVdirectionVthatVbeginsVwithVassessingVandVcontinuesVthroughVdiagnosin
g,Vplanning,VandVfinallyVimplementing
d. AnVongoingVprocessVthatVbeginsVwithVassessingVandVcontinuesVwithVdiagnosin
g,Vplanning,Vimplementing,VandVevaluating
ANS:V D
TheVnursingVprocessVisVanVongoing,Vflexible,Vadaptable,VandVadjustableVfive-
stepVprocessVthatVbeginsVwithVassessingVandVcontinuesVthroughVdiagnosing,Vplanning,Vimplementing,Van
chVmayVthenVleadVbackVtoVanyVofVtheVotherVphases.
DIF: CognitiveVLevel:VApplication
9. WhenVtheVnurseVisVconsideringVtheVtimingVofVaVdrugVdose,VwhichVisVmostVimportantVtoVassess?
a. TheVpatient’sVidentification
b. TheVpatient’sVweight
c. TheVpatient’sVlastVmeal
d. AnyVdrugVorVfoodVallergies
ANS:V C
TheVpharmacokineticVandVpharmacodynamicVpropertiesVofVtheVdrugVneedVtoVbeVassessedVwithVregardVto
foodVinteractionsVorVcompatibilityVissues.VTheVpatient’sVidentification,Vweight,VandVdrugVorVfoodVallergie
ug’sVtiming.
DIF: CognitiveVLevel:VApplication
10. TheVnurseVisVwritingVnursingVdiagnosesVforVaVplanVofVcare.VWhichVreflectsVtheVcorrectVformatVforVherVnu
a. Anxiety
b. AnxietyVrelatedVtoVnewVdrugVtherapy
c. AnxietyVrelatedVtoVanxiousVfeelingsVaboutVdrugVtherapy,VasVevidencedVb
yVstatementsVsuchVasV“I’mVupsetVaboutVhavingVtoVgiveVmyselfVshots”
d. AnxietyVrelatedVtoVnewVdrugVtherapy,VasVevidencedVbyVstatementsVsuchVasV“I’
mVupsetVaboutVhavingVtoVgiveVmyselfVshots”
, lOMoAR cPSD| 13728229
Chapter 02: Pharmacological Principles
V V V
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
V V V V V V V V V
MULTIPLEVCHOICE
1. AVpatientVisVreceivingVtwoVdifferentVdrugs,Vwhich,VatVtheirVcurrentVdoseVformsVandVdosages,VareVbothVab
VinVidenticalVamounts.VWhichVtermVbestVdenotesVthatVtheVdrugsVhaveVtheVsameVabsorptionVrates?
a. Equivalent
b. Synergistic
c. Compatible
d. Bioequivalent
ANS:V D
TwoVdrugsVabsorbedVintoVtheVcirculationVatVtheVsameVamountV(inVspecificVdosageVforms)VhaveVtheVsame
areVbioequivalent.V“Equivalent”VisVincorrectVbecauseVtheVtermV“bioavailability”VisVusedVtoVexpressVtheVe
ynergistic”VisVincorrectVbecauseVthisVtermVrefersVtoVtwoVdrugsVgivenVtogetherVwhoseVresultingVeffectVisV
effectsVofVeachVdrugVgivenValone.V“Compatible”VisVincorrectVbecauseVthisVtermVisVaVgeneralVtermVusedVt
esVdoVnotVhaveVaVchemicalVreactionVwhenVmixedV(orVgiven,VinVtheVcaseVofVdrugs)Vtogether.
DIF: CognitiveVLevel:VComprehension
2. AVpatientVisVreceivingVmedicationVviaVintravenousVinjection.VWhichVinformationVshouldVtheVnurseVprov
a. TheVmedicationVwillVcauseVfewerVadverseVeffectsVwhenVgivenVintravenously.
b. TheVmedicationVwillVbeVabsorbedVslowlyVintoVtheVtissuesVoverVtime.
c. TheVmedication’sVactionVwillVbeginVfasterVwhenVgivenVintravenously.
d. MostVofVtheVdrugVisVinactivatedVbyVtheVliverVbeforeVitVreachesVtheVtargetVarea.
ANS:V C
IntravenousVinjectionsVareVtheVfastestVrouteVofVabsorption.VTheVintravenousVrouteVdoesVnotVaffectVtheVnu
heVintravenousVrouteVisVnotVaVslowVrouteVofVabsorption,VandVtheVintravenousVrouteVdoesVnotVcauseVinacti
liverVbeforeVitVreachesVtheVtargetVarea.
DIF: CognitiveVLevel:VComprehension
3. WhichVisVtrueVregardingVparenteralVdrugs?
a. TheyVbypassVtheVfirst-passVeffect.
b. TheyVdecreaseVbloodVflowVtoVtheVstomach.
c. TheyVareValteredVbyVtheVpresenceVofVfoodVinVtheVstomach.
d. TheyVexertVtheirVeffectsVwhileVcirculatingVinVtheVbloodstream.
ANS:V A
DrugsVgivenVbyVtheVparenteralVrouteVbypassVtheVfirst-
passVeffect,VbutVtheyVstillVmustVbeVabsorbedVintoVcellsVandVtissuesV beforeVtheyVcanVexertVtheirVeffects.VEn
lly),VnotVparenteralVdrugs,VdecreaseVbloodVflowVtoVtheVstomachVandVareValteredVbyVtheVpresenceVofVfood
drugsVmustVbeVabsorbedVintoVcellsVandVtissuesVfromVtheVcirculationVbeforeVtheyVcanVexertVtheirVeffects;V
tsVwhileVcirculatingVinVtheVbloodstream.
DIF: CognitiveVLevel:VAnalysis
4. AVdrug’sVhalf-lifeVisVbestVdefinedVas
a. TheVtimeVitVtakesVforVtheVdrugVtoVelicitVhalfVitsVtherapeuticVresponse.
b. TheVtimeVitVtakesVone-
halfVofVtheVoriginalVamountVofVaVdrugVtoVreachVtheVtargetVcells.
c. TheVtimeVitVtakesVone-
halfVofVtheVoriginalVamountVofVaVdrugVtoVbeVremovedVfromVtheVbody.
d. TheVtimeVitVtakesVone-
halfVofVtheVoriginalVamountVofVaVdrugVtoVbeVabsorbedVintoVtheVcirculation.
ANS:V C
